Diseases [C] » Nervous System Diseases [C10] » Central Nervous System Diseases
Description
Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord. MeSH
Hierarchy View
Subtype Terms (8)
Brain Diseases
129 drugs (78 approved, 51 experimental)
Central Nervous System Infections
8 drugs (7 approved, 1 experimental)
Movement Disorders
30 drugs (16 approved, 14 experimental)
Ocular Motility Disorders
3 approved drugs
Pneumocephalus
1 approved drug
Spinal Cord Diseases
21 drugs (16 approved, 5 experimental)
Approved Indicated Drugs (1)
Phase 4 Indicated Drugs (16)
Phase 2 Indicated Drugs (21)
Phase 1 Indicated Drugs (19)
Other Experimental Indicated Drugs (6)
Organization Involved with Phase 4 Indications (6)
Organization Involved with Phase 3 Indications (5)
Organization Involved with Phase 2 Indications (34)
Organization Involved with Phase 1 Indications (15)
Organization Involved with Other Experimental Indications (4)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
